Page 10 - Given Imaging News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com's offering. The global smart pill market as a whole will reach $6.34 billion by 2026, growing by 18% CAGR Select Report Findings: North America is the largest region, followed by Asia Pacific and Europe through the study period Tools and technologies in support of smart pills will reach $2.9 billion by 2026, growing by 23% CAGR The market for smart pill related data storage and analytics software will reach $437 million globally by 2026, growing at 28% CAGR Hospitals and clinics remain the largest distribution channel, but home h...

Does this report provide customization? Customization helps organizations gain insight into specific market segments and areas of interest. Therefore, Market Info Reports provides customized report information according to business needs for strategic calls. Get Customization of the Report@: Why Choose Market Info Reports?: Market Info Reports Research delivers strategic market research reports, industry analysis, statistical surveys and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SME’s, indiv...

Follow Apr. 12, 2021 Tzahi Nahmias was already very rich when he acquired Discount Investment Corp. a few months ago. But he doesn’t play the role of tycoon: He doesn’t work around the clock and his property company, Mega Or, occupies modest offices in Moshav Shilat with a discount supermarket on the ground level. He and his family live in the same moshav. “If you know how to make the right decisions and have a team you can rely on, you don’t need to be working 24/7,” he once told an associate. But those who have done business with Nahmias say there’s a difference between his pub...

Kadimastem hopes to turn corner with new management The Israeli stem cell technology company has named Asaf Shiloni CEO, after three new expert directors joined its board. Israeli stem cell technology company Kadimastem (TASE: KDST) has had a chequered history, with frequent going concern warnings on its financials, a downward drifting share price from its 2016 peak, and the departure last year of founder and CEO Yossi Ben-Yosef. The company now hopes to have turned a corner with the appointment of a new and experienced CEO and new directors. Kadimastem has named Asaf Shiloni, who was Vice Pr...

Kadimastem Announces Executive Management Changes USA - English Accomplished US Life Science and Biotech Executive Asaf Shiloni Named New CEO Company Appoints Biotech Industry Leaders Ronen Twito, CPA as Co-Chairperson and Doron Birger and Ron Mayron to the Company's Board of Directors News provided by Share this article NESS ZIONA, Israel, Feb. 1, 2021 /PRNewswire/ --  Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announces the appointment of Asaf Shiloni as CEO. This follows a series of executive management appointments in the last month including Mr. Ronen Twito, CP...